Amplia Therapeutics (ASX:ATX) Secures Grant Funding for Collaborative Research with CSIRO
Kalkine Media, Other, 22/05/2023
Amplia Therapeutics, a leading biotechnology company listed on the Australian Securities Exchange (ASX) under the ticker symbol ATX, has recently announced that it has secured grant funding for collaborative research with CSIRO (Commonwealth Scientific and Industrial Research Organisation). This partnership aims to further advance the development of novel therapeutics targeting diseases with high unmet medical needs.